Resveratrol inhibits MUC5AC expression by regulating SPDEF in lung cancer cells

• Published in: Phytomedicine (Stuttgart) Vol. 89; p. 153601
• Main Authors: Lin, Yu-hua, Zhu, Lin-yun, Yang, Yan-qin, Zhang, Zhu-hua, Chen, Qing-ge, Sun, Yi-peng, Bi, Jun-jie, Luo, Xu-ming, Ni, Zhen-hua, Wang, Xiong-biao
• Format: Journal Article
• Language: English
• Published: Elsevier GmbH 01-08-2021
• Subjects: Chemosensitivity; MUC5AC; Mucinous adenocarcinoma; Resveratrol; SPDEF; Res; NSCLC; DMSO; MUC5B; LY; MUC5AC; LUAD; DDP; p-AKT; Resveratrol; Chemosensitivity; Mucinous adenocarcinoma; p-ERK; SPDEF
• ISSN: 0944-7113; 1618-095X
• DOI: 10.1016/j.phymed.2021.153601

MUC5AC was recently identified to play important roles in the proliferation and metastasis of malignant mucinous lung tumor cells. Resveratrol (Res), a natural compound with anticancer effects in lung cancer cells, has been reported to inhibit mucin production in airway epithelial cells. This study aimed to investigate the inhibitory effect of Res on MUC5AC expression in lung mucinous adenocarcinoma cells and the potential mechanisms.
Mucus-producing A549 human lung carcinoma cells were used to test the effects of Res on SPDEF and MUC5AC expression. Gene and protein expression was assessed by real-time quantitative PCR (qPCR), immunofluorescence and western blotting assays. SPDEF lentivirus was used to upregulate SPDEF expression levels in mucus-producing A549 human lung carcinoma cells. Cell proliferation was assessed by Cell Counting Kit-8 (CCK-8) assay.
Res decreased MUC5AC expression in an SPDEF-dependent manner in mucus-producing A549 human lung carcinoma cells, and this change was accompanied by decreased ERK expression and AKT pathway activation. Moreover, SPDEF was found to be overexpressed in lung adenocarcinoma (LUAD), especially in mucinous adenocarcinoma. In-vitro functional assays showed that overexpression of SPDEF reduced the chemosensitivity of A549 cells to cisplatin (DDP). In addition, Res treatment increased A549 cell chemosensitivity to DDP by inhibiting the SPDEF-MUC5AC axis.
Our results indicate that the SPDEF-MUC5AC axis is associated with DDP sensitivity, and that Res decreases SPDEF and MUC5AC expression by inhibiting ERK and AKT signaling in A549 cells, which provides a potential pharmacotherapy for the prevention and therapeutic management of mucinous adenocarcinoma.